Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H23NS |
Molecular Weight | 249.415 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CCN(CC1)C2(CCCCC2)C3=CC=CS3
InChI
InChIKey=JUZZEWSCNBCFRL-UHFFFAOYSA-N
InChI=1S/C15H23NS/c1-3-9-15(10-4-1,14-8-7-13-17-14)16-11-5-2-6-12-16/h7-8,13H,1-6,9-12H2
Tenocyclidine (TCP) is a dissociative anesthetic drug with psychostimulant and hallucinogenic effects. This drug shows a broad spectrum of pharmacological activity including antidotal effect in organophosphorus compounds poisoning, radioprotective and anticancer effects. It was studied that the antidotal potency could protect acetylcholinesterase (AChE) in the case of organophosphate poisoning. However, the controversial role of TCP in brain protection should be studied further. Tenocyclidine has a high affinity for the N-methyl-D-aspartate (NMDA) receptors. This property allows using of TCP binding (association rate) as a marker of channel opening and thereby permitting measurement of NMDA receptor activation and ligand binding under identical conditions.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. | 2001 Dec |
|
Effects of thienylphencyclidine (TCP) on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neurotoxicity. | 2001 Feb |
|
Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex. | 2002 Mar |
|
Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites. | 2002 May 1 |
|
Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants. | 2003 Dec |
|
Influences of different developmental periods of taurine supplements on synaptic plasticity in hippocampal CA1 area of rats following prenatal and perinatal lead exposure. | 2007 May 19 |
|
Molecular properties of local anesthetics as predictors of affinity for nicotinic acetylcholine receptors. | 2007 Oct |
|
Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody. | 2008 Jan |
|
High specific activity tritiation of TCP and BTCP. | 2009 Jun |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
||
|
DEA NO. |
7470
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082930
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
DTXSID3046168
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
4898
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
64610
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
C012058
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
SUB10896MIG
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
62751
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
DB01520
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
C96892
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL279676
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
TENOCYCLIDINE
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
7637
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
8BQ45Q6VCL
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY | |||
|
21500-98-1
Created by
admin on Fri Dec 15 15:38:22 GMT 2023 , Edited by admin on Fri Dec 15 15:38:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)